2007-09-18 15:30:00 CEST

2007-09-18 15:30:00 CEST


REGULATED INFORMATION

English Finnish
Biohit Oyj - Company Announcement

BIOHIT BEGINS TEST MARKETING OF ITS XYLICYST CHEWING GUM


Biohit Oyj has begun to test market the XyliCyst chewing gum, a functional food 
product, through an online shop (www.verkkoapteekki.fi). At this stage, it is   
difficult to estimate the impact of this test marketing on the total net sales  
of the Biohit Group in 2007.                                                    

Verkkoapteekki.fi is a Finnish online shop selling health care products and     
articles via Internet.                                                          

The XyliCyst chewing gum eliminates acetaldehyde that dissolves in saliva during
tobacco smoking. Research studies have shown that acetaldehyde is a major risk  
factor for cancers of the upper gastrointestinal tract and that it may increase 
addiction to tobacco products. XyliCyst is developed and marketed by Biohit and 
manufactured by Fennobon Oy.                                                    

Biohit Oyj                                                                      
Osmo Suovaniemi                                                                 
President & CEO                                                                 


Further information:                                                            

Osmo Suovaniemi, M.D., Ph.D., Professor                                         
President & CEO                                                                 
Tel: +358-9-773 861                                                             
Mobile: +358-40-745 5605                                                        
Email: osmo.suovaniemi@biohit.com                                               

Distribution:                                                                   

Helsinki Exchanges                                                              
Financial Supervisory Authority                                                 
Press                                                                           
http://www.biohit.com